[Form 4] Flex Ltd. Insider Trading Activity

Rhea-AI Filing Summary

Erin L. McSweeney, a Director of Flex Ltd. (FLEX), reported a sale of company stock. On 08/22/2025 she disposed of 10,000 ordinary shares at a weighted average price of $51.4711 per share (actual prices ranged from $51.47 to $51.505). After the sale she beneficially owned 17,012 shares in total. That total includes 4,713 unvested restricted share units (RSUs) which vest in full the day before the issuer's 2026 annual general meeting; each RSU converts to one unrestricted share upon vesting. The Form 4 was signed on 08/25/2025 by Erin L. McSweeney via attorney-in-fact Kristine Murphy.

Positive

• Disclosure includes RSU vesting detail showing 4,713 unvested RSUs that vest prior to the 2026 annual general meeting
• Weighted-average sale price provided with range of actual sale prices disclosed for transparency

Negative

• Insider sale of 10,000 shares on 08/22/2025 could be perceived negatively by some investors
• Post-transaction beneficial ownership is limited at 17,012 shares, indicating relatively small remaining direct stake

Insights

Financial Analyst

TL;DR: Director sold 10,000 shares; remaining beneficial ownership is 17,012 including 4,713 unvested RSUs.

The filing documents a single non-derivative sale of 10,000 ordinary shares on 08/22/2025 at a weighted average price of $51.4711. The post-transaction beneficial position of 17,012 shares is modest in absolute terms; a material portion of that position (4,713) is held as unvested RSUs that convert to common shares only if they vest before the 2026 annual meeting. There is no information in the filing about intentions, pre-arranged trading plans, or other concurrent transactions. For investors, this is a routine insider sale disclosure rather than a corporate event affecting operating performance.

Corporate Governance Expert

TL;DR: Transaction appears to be a routine Section 16 disclosure of an insider sale and RSU holdings.

The Form 4 correctly reports the director relationship, the sale transaction code, and provides the weighted average sale price with the customary caveat on per-price breakdowns. The filing notes the existence and vesting schedule of 4,713 RSUs, which is useful for assessing potential future dilution or insider alignment. The document does not indicate any amendment, Rule 10b5-1 plan checkbox, or other governance signals beyond standard disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McSweeney Erin

(Last) (First) (Middle)

C/O FLEXTRONICS INTERNATIONAL USA, INC.

12515-8 RESEARCH BLVD, SUITE 300

(Street)

AUSTIN TX 78759

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FLEX LTD. [ FLEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/22/2025		S		10,000	D	$51.4711(1)	17,012(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Price reflects weighted average sales price; actual sales prices ranged from $51.47 to $51.505. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

2. Includes 4,713 unvested restricted share units ("RSUs"), which vest in full on the date immediately prior to the date of Issuer's 2026 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferrable share for each vested RSU which has not been previously forfeited.

Remarks:

	/s/ Erin L. McSweeney, by Kristine Murphy as attorney-in-fact	08/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did FLEX director Erin McSweeney report on Form 4?

The Form 4 reports a sale of 10,000 ordinary shares on 08/22/2025 at a weighted average price of $51.4711, with 17,012 shares beneficially owned after the sale.

How many unvested RSUs does Erin McSweeney hold and when do they vest?

The filing states 4,713 unvested restricted share units (RSUs) that vest in full on the date immediately prior to the issuer's 2026 annual general meeting.

What price range did the sale occur at according to the Form 4?

The reporting person states the actual sales prices ranged from $51.47 to $51.505, with the weighted average price reported as $51.4711.

When was the Form 4 signed?

The signature block shows the Form 4 was signed on 08/25/2025 by Erin L. McSweeney via attorney-in-fact Kristine Murphy.

Does the filing indicate a Rule 10b5-1 trading plan or other pre-arranged plan?

The Form 4 does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan; no such box or plan disclosure is present in the provided content.